子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 41 | 술파이드 또는 술폰기가 치환된 불소화 비닐옥시아세트아미드 유도체, 이의 제조 방법 및 이를 포함하는 제초제 조성물 | KR1019990038013 | 1999-09-08 | KR1020010026621A | 2001-04-06 | 김범태; 민용기; 박노균; 김영섭; 홍경식; 권용웅; 박재읍 |
| PURPOSE: The title compound having a new structure in which a sulfide or sulfon group substituted fluorinated vinyl group is introduced into oxyacetamide derivatives and herbicidal composition containing the same as an effective component are provided which have excellent herbicidal activity. CONSTITUTION: The sulfide or sulfon group substituted fluorinated vinyloxyacetamide derivatives of formula 1 is prepared by a process consisting of: reacting alcoholic compounds of formula 2 and fluorinated vinyl compounds of formula 3 in the presence of a base. In formula, R1 is C1-4 alkyl, C2-4 alkenyl or nonsubstituted or C1-4 alkyl, haloalkyl, alkoxy, Cl, F or F substituted phenyl; R2 is C1-4 alkyl or C2-4 alkenyl; R3 is C1-4 alkyl or phenyl; R4 is C1-4 alkyl or, nonsubstituted Cl, F or Br substituted phenyl; R5 is F or trifluormethyl; n is 0 or 2. | ||||||
| 42 | 알킬 티올 히드록사 메이트 및 그 유도체의 제조 방법 | KR1019850009112 | 1985-12-04 | KR1019860004849A | 1986-07-14 | 조할오렌 |
| 43 | ANTIBACTERIAL S-HETEROSUBSTITUTED DISULFIDES | US12765272 | 2010-04-22 | US20100204337A1 | 2010-08-12 | Edward Turos; Praveen Ramaraju |
| Synthetically-derived S,S-heterodisubstituted disulfides that exhibit potent in vitro antibacterial activity against a variety of bacteria, including Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Francisella tularensis. The present invention provides compounds, methods and compositions effective to treat microbial/bacterial infections, and, especially, infections arising from bacteria which have developed resistance to conventional antibiotics. | ||||||
| 44 | Therapeutic agents useful for treating pain | US11478462 | 2006-06-28 | US07754723B2 | 2010-07-13 | Qun Sun; Laykea Tafesse |
| Compounds of formulae: where Ar1, Ar2, R3, R4, and m are disclosed herein, or a pharmaceutically acceptable salt thereof (a “Nitro(cyano)vinylpiperazine Compound”); compositions comprising an effective amount of a Nitro(cyano)vinylpiperazine Compound; and methods for treating or preventing pain and other conditions in an animal comprising administering to an animal in need thereof an effective amount of a Nitro(cyano)vinylpiperazine Compound are disclosed. | ||||||
| 45 | Bis(3-alkoxypropan-2-ol) sulfides, sulfoxides, and sulfones: new preparative methods | US11527116 | 2006-09-26 | US20070149821A1 | 2007-06-28 | Andrew Wang; Kevin Lassila; Michael Ford; Joseph Krock; Nancy Martin; Ge Zhang |
| Compounds according to formula (I) wherein Z is S, SO, or SO2, may be prepared by a process that includes charging to a reactor hydrogen sulfide and an alkyl glycidyl ether according to formula (III), in the presence of a base. The compounds may also be prepared by contacting an alkoxychlorohydrin according to formula (II) with a sulfide source. | ||||||
| 46 | 1-methoxy-3-hexanethiol and its S-acetyl derivative as perfuming and flavoring ingredients | US373906 | 1999-08-13 | US6129941A | 2000-10-10 | Sina Dorothea Escher; Matthijs Van De Waal |
| A compound of formula ##STR1## wherein R represents a hydrogen atom or an acetyl group, is useful in perfumery and in the field of flavors. The compound of formula (I) confer an odor and flavor effect extremely powerful of the clary-sage type, even when used in small amounts. | ||||||
| 47 | Fluoro-substituted alkyl ether compounds, liquid crystal compositions and liquid crystal display devices | US147387 | 1998-12-14 | US6124005A | 2000-09-26 | Tomoyuki Kondo; Shuichi Matsui; Kazutoshi Miyazawa; Hiroyuki Takeuchi; Fusayuki Takeshita; Etsuo Nakagawa |
| Liquid crystalline compounds which have excellent compatibility with other liquid crystal materials, especially at low temperatures, high voltage holding ratio, low threshold voltage, their small temperature dependency, high .DELTA.n, and broad liquid phase temperature range, the compounds being represented by formula (1)Ra--A.sub.1 --Z.sub.1 --A.sub.2 --Z.sub.2 --(--A.sub.3 --Z.sub.3 --).sub.m --A.sub.0 --Rf (1)(wherein m is 0 or 1; A.sub.0, A.sub.1, A.sub.2 and A.sub.3 represent a six-membered ring, ring A.sub.0 is 1,4-phenylene which may be substituted with 1 to 3 of F and/or Cl, rings A.sub.1, A.sub.2 and A.sub.3, independently of one another, are selected from trans-1,4-cyclohexylene, 1,4-phenylene which may be substituted with one or more halogen atoms, cyclohexene-1,4-diyl or 1,3-dioxane-2,5-diyl; Z.sub.1, Z.sub.2 and Z.sub.3 represent a bridge between the rings and independently of one another, are selected from --(CH.sub.2).sub.2 --, --(CH.sub.2).sub.4 --, --CH.sub.2 O--, --OCH.sub.2 -- bonds, one or more hydrogen atoms in these bonds being optionally substituted with a halogen atom, or a single bond (--); Rf represents --OCF.sub.2 CF.sub.2 H or --OCF.sub.2 CFHCF.sub.3 ; and Ra is a straight- or branched monovalent organic radical of 1 to 20 carbons); liquid crystal compositions comprising at least one of the compounds; and liquid crystal display devices composed of the compositions. | ||||||
| 48 | Tertiary amines | US762827 | 1996-12-06 | US6034275A | 2000-03-07 | Johannes Aebi; Henrietta Dehmlow; Jacques Himber; Synese Jolidon; Hans Lengsfeld; Olivier Morand; Gerard Schmid; Ku-Hua Ji |
| Tertiary amines of the formula ##STR1## wherein A.sup.1, A.sup.2, A.sup.3, A.sup.4, L, M, p, T, and Q are as defined herein, have antimycotic and cholesterol-lowering activity. | ||||||
| 49 | Precious metal composition | US009126 | 1998-01-20 | US6013798A | 2000-01-11 | Peter T Bishop |
| Gold thiolates of formula AuSR" or a salt thereof, in which R" is such that HSR" represents: 4,6-dihydroxy-2-mercaptopyrimidine;N-(2-mercaptoacetyl)glycine;N-(3-mercaptopropionyl)glycine; andN-(2-mercaptopropionyl)glycine. The invention provides also processes for preparing novel gold thiolates. | ||||||
| 50 | .delta.-amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides | US687878 | 1996-07-25 | US5627182A | 1997-05-06 | Richard G oschke; J urgen K. Maibaum; Walter Schilling; Stefan Stutz; Pascal Rigollier; Yasuchika Yamaguchi; Nissim C. Cohen; Peter Herold |
| .delta.-Amino-.gamma.-hydroxy-.omega.-aryl-alkanoic acid amides of formula I ##STR1## and the salts thereof, have renin-inhibiting properties and can be used as antihypertensive medicinal active ingredients. | ||||||
| 51 | Meta-substituted aromatic compounds having six-membered rings, for use in liquid-crystal mixtures | US88849 | 1993-07-07 | US5447656A | 1995-09-05 | Dietmar Jungbauer; Hubert Schlosser |
| Meta-substituted aromatic compounds having six-membered rings, for use in liquid-crystal mixturesCompounds of the formula I ##STR1## in which X is CH, CF or N,R.sup.2 is, for example, an alkyl, ether or ester group, which may also contain a chiral center, andR.sup.1 (--A.sup.1).sub.a (--M.sup.1).sub.b (--A.sup.2).sub.c (--M.sup.2) .sub.d (--A.sub.3).sub.e (--M.sub.3).sub.f is a mesogenic radical,can advantageously be used as components of liquid-crystal mixtures, in particular ferroelectric liquid-crystal mixtures.The substances of the formula I have a particularly favorable effect on the optical switching angle and the critical pulse area of the mixtures. | ||||||
| 52 | Benzene derivatives, and liquid-crystalline medium | US239830 | 1994-05-09 | US5422035A | 1995-06-06 | Ekkehard Bartmann; Herbert Plach; Andreas Ruhl |
| A liquid-crystalline medium based on a mixture of polar compounds having positive dielectric anisotropy, comprising one or more compounds of the formula I ##STR1## in which R, A.sup.1,. A.sup.2, Z.sup.1, Z.sup.2, m, n, L.sup.1, L 2 and L.sup.3 are as defined in claim 1. | ||||||
| 53 | N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines | US837258 | 1992-02-14 | US5322858A | 1994-06-21 | Craig Canfield; David P. Jacobus; Neil J. Lewis |
| There are provided compounds of the formula ##STR1## wherein R.sup.1 is a substituted or unsubstituted divalent aliphatic group of 1 to 16 carbon atoms; wherein the substituents are mono or poly and are selected from the group consisting of lower alkyl, aryl and arlkyl, R.sup.3 is selected from the group consisting of same group of values as R.sup.5, R.sup.5 is selected from the group consisting of substituted and unsubstituted alkyl of 1-10 carbon atoms, aryl, cycloalkyl and heterocycloalkyl of 3-8 carbon atoms, wherein the substituents are mono or poly and are selected from the group consisting of lower alkyl, cycloalkyl of 3-8 carbon atoms, lower alkenyl, lower alkynyl, nitro, lower alkoxy, lower alkoxycarbonyl, phenyl loweralkyl, phenyl, mono and polyhalophenyl, phenoxy, mono and polyhalophenoxy, R.sup.6 and R.sup.7 may be the same or different and are hydrogen, alkanoyl or alkoxyalkanoyl, R.sup.7 may also have the same value as R.sup.5, Y is oxygen or sulfur, m is 0 or 1, q is 0 or 1, wherein the prefix alk designates moieties which are straight chain or branched chain, and the term lower designates 1-6 carbon atoms and the unmodified term alk signifies 1-24 carbon atoms, the respective tautomers thereof, the pharmaceutically acceptable salts and addition salts thereof and the hydrates of said salts and addition salts. There are further provided methods of protecting subjects liable thereto from infections caused by an organism of the group Plasmodium sp., Mycobacterium sp. and Pneumocystis carinii by administering to a subject liable to such infection, a prophylactically effective amount of a compound of the foregoing formula. These compounds will also reduce the level of infection where said subjects have already been infected. | ||||||
| 54 | Esters of 3-tert-butyl- and 3-tert-butyl-5-alkyl-4-hydroxyphenyl (alkane) carboxylic acids with oxyethylates of polythiols | US122724 | 1987-11-18 | US4906775A | 1990-03-06 | Friedrich-Wilhelm Kupper; Heinz-Werner Voges; Hans-Jurgen Haage |
| Esters of 3-tert-butyl- and 3-tert-butyl-5-alkyl-4-hydroxyphenyl (alkane) carboxylic acids with oxyethylates of polythiols are useful as stabilizers for polymers, especially for polyethylene and polypropylene. | ||||||
| 55 | Phenylacetic acid derivatives, their preparation, compositions containing same derivative, a method for controlling animal pests or harmful fungi using the derivatives, their use, and intermediates | JP51624697 | 1996-10-11 | JP4060359B2 | 2008-03-12 | アマーマン，エーバーハルト; キルストゲン，ラインハルト; グロテ，トーマス; ザウター，フーベルト; シュトラトマン，ズィークフリート; バイァ，ヘルベルト; ハリース，フォルカー; ミュラー，ルート; ロレンツ，ギーゼラ |
| 56 | Cyano compound and method for producing the same | JP2005297761 | 2005-10-12 | JP2006045245A | 2006-02-16 | BORDAS-NAGY JOSEPH; GORYCKI PETER; WEBB KEVIN SCOTT |
| PROBLEM TO BE SOLVED: To provide a new phenylcyclohexan-1-ylcarboxylic acid, a pharmaceutical composition containing the compound, the use of the compound in treating allergic and inflammatory diseases and the use of the compound to inhibit the production of a tumor necrosis factor (TNF). SOLUTION: The compound useful as a PDE (phosphodiesterase) IV inhibitor and for treatment of disease associated therewith is represented by structural formula (I). COPYRIGHT: (C)2006,JPO&NCIPI | ||||||
| 57 | Synthesis of benzo [f] quinolinone | JP2000554705 | 1999-06-01 | JP2002518375A | 2002-06-25 | ペリー・クラーク・ヒース |
| (57)【要約】 中間体、及び、ベンゾキノリン-３-オン医薬の製造方法であって、このような医薬は、５α還元酵素により生じる症状を処置するのに有効である。 | ||||||
| 58 | Precious metal composition | JP12328992 | 1992-05-15 | JP3119390B2 | 2000-12-18 | トレントン ビショップ ピーター |
| 59 | Production for organic compound | JP10999599 | 1999-04-16 | JP2000080049A | 2000-03-21 | NOBORI TADAHITO; HAYASHI TAKAOMI; HARA RETSU; KIYONO SHINJI; SHIBAHARA ATSUSHI; FUNAKI KATSUHIKO; URAGAMI TATSUNOBU; TAKUMA HIROSUKE; TAKAGI USAJI |
| PROBLEM TO BE SOLVED: To effectively obtain an organic compound under a mild condition in high yield by performing an organic reaction in the presence of a specific phosphine oxide compound. SOLUTION: This organic compound is produced by performing an organic reaction in the presence of a phosphine oxide compound of formula I [R1 is H or a 1-10C hydrocarbon; (x) is 0-5.0]. An oxyalkylene derivative is produced preferably in the presence of the compound of formula I by reacting an epoxy compound with an alcohol, etc., of the formula: H-Q (H is an active hydrogen atom; Q is an organic group formed by removal of the active hydrogen atom from the alcohol, etc.), a carboxylic acid ester of formula II, a carboxylic acid anhydride of formula III, a sulfonic acid ester of formula IV (R2 is H or a 1-35C organic group; OZ1 is an organic group formed by removal of the active hydrogen atom from the alcohol, etc.; OZ2 is an organic group formed by removal of the active hydrogen atom from a carboxylic acid) or a carbonate of formula V (R3 is a 1-35C fatty hydrocarbon, etc.). | ||||||
| 60 | Reagent and method for solid-phase synthesis and display | JP17612999 | 1999-06-22 | JP2000044494A | 2000-02-15 | MCGALL GLENN H; BARONE ANTHONY D; DIGGELMANN MARTIN |
| PROBLEM TO BE SOLVED: To provide a new compound bearing asymmetric disulfide linking group that is useful for an array preparation in solid-phase synthesis and a small ligand molecule and permits rapid and mild separation of the synthesized molecule from the solid supporter. SOLUTION: This compound is represented by the formula: P1-X1-(W1)m-X2-P2 (P1 and P2 are each an activated group or the like; X1 and X2 are each a bond, -O- or the like; W1 and W2 are each methylene or the like; n and m are each 2-12; where in case of W1=W2, n is ≠m and both of P1 and P2 are not H), typically a compound of the formula (DMT is dimethoxytrityl). This new compound is prepared, for example, by treatment of 6-bromohexanol as a starting substance with allyl chloroformate, conversion of the product to a thiol, introduction of a disulfide functional group with 2-pyridyl-2-hydroxyethyl disulfide, protection of the terminal OH group, removal of allyl carbonate and introduction of phosphoramidite at the resultant OH group. COPYRIGHT: (C)2000,JPO | ||||||
QQ群二维码
意见反馈
意见反馈